{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:41:44Z","timestamp":1770504104583,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1378\/chest.125.6.2135","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T19:20:47Z","timestamp":1086808847000},"page":"2135-2139","source":"Crossref","is-referenced-by-count":78,"title":["Levofloxacin Efficacy in the Treatment of Community-Acquired Legionellosis"],"prefix":"10.1016","volume":"125","author":[{"given":"Victor L.","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard N.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neringa","family":"Zadeikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet E.","family":"Stout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed M.","family":"Khashab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan M.","family":"Tennenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.125.6.2135_bib1","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1378\/chest.105.6.1817","article-title":"Legionnaires disease","volume":"105","author":"Roig","year":"1994","journal-title":"Chest"},{"key":"10.1378\/chest.125.6.2135_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0272-5231(21)00742-5","article-title":"Legionella infection","volume":"12","author":"Nguyen","year":"1991","journal-title":"Clin Chest Med"},{"key":"10.1378\/chest.125.6.2135_bib3","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/AAC.42.12.3153","article-title":"Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.","volume":"42","author":"Baltch","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 3","key":"10.1378\/chest.125.6.2135_bib4","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1093\/clind\/21.Supplement_3.S265","article-title":"Antimicrobial chemotherapy for Legionnaires disease: a review","volume":"21","author":"Edelstein","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.125.6.2135_bib5","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.1994.00420210049006","article-title":"Surveillance for Legionnaires disease: risk factors for morbidity and mortality","volume":"154","author":"Marston","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.125.6.2135_bib6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199709043371006","article-title":"Legionellosis","volume":"337","author":"Stout","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.6.2135_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.125.6.2135_bib8","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.125.6.2135_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1469-0691.2002.00392.x","article-title":"In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe","volume":"8","author":"Critchley","year":"2002","journal-title":"Clin Microbiol Infection"},{"key":"10.1378\/chest.125.6.2135_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0732-8893(97)00174-0","article-title":"Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells","volume":"30","author":"Stout","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1378\/chest.125.6.2135_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jac\/40.5.673","article-title":"Effect of levofloxacin, erythromycin or rifampicin pretreatment of growth of Legionella pneumophila in human monocytes","volume":"40","author":"Smith","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.125.6.2135_bib12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1378\/chest.119.4.1114","article-title":"Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects","volume":"119","author":"Gotfried","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.125.6.2135_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/46.5.669","article-title":"Application of fluoroquinolone pharmacodynamics","volume":"46","author":"Wright","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.125.6.2135_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.125.6.2135_bib15","series-title":"Erythromycin versus fluoroquinolones in the treatment of Legionnaires disease. Presented at the 41st Interscience Conference for Antimicrobial Agents and Chemotherapy","author":"Pedro-Botet","year":"2001"},{"key":"10.1378\/chest.125.6.2135_bib16","first-page":"1049","article-title":"Can Legionnaires disease be diagnosed by clinical criteria?","volume":"120","author":"Mulazimoglu","year":"2001","journal-title":"A critical review. Chest"},{"key":"10.1378\/chest.125.6.2135_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00019048-199811000-00009","article-title":"Once a day levofloxacin in the treatment of mild to moderate and severe community-acquired pneumonia in adults","volume":"7","author":"Fogarty","year":"1998","journal-title":"Infect Dis Clin Pract"},{"key":"10.1378\/chest.125.6.2135_bib18","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.41.9.1965","article-title":"A multicenter, randomized study comparing the efficacy and safety of intravenous and\/or oral levofloxacin versus ceftriaxone and\/or cefuroxime axetil in treatment of adults with community-acquired pneumonia","volume":"41","author":"File","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl","key":"10.1378\/chest.125.6.2135_bib19","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/378406","article-title":"Multicenter, open-label, randomized study to compare the safety and efficacy of levofloxacin vs ceftriaxone sodium and erythromycin followed by clarithromycin and amoxicillin\/clavulanate in the treatment of serious community-acquired pneumonia in adults","volume":"38","author":"Fogarty","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.125.6.2135_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.125.6.2135_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1086\/377539","article-title":"High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm","volume":"37","author":"Dunbar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.125.6.2135_bib22","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1345\/aph.1C167","article-title":"Fluoroquinolone treatment of community-acquired pneumonia: a meta-analysis","volume":"36","author":"Salkind","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1378\/chest.125.6.2135_bib23","first-page":"32","article-title":"Community-acquired Legionnaires disease","volume":"4","author":"Muder","year":"1989","journal-title":"Semin Respir Infect"},{"key":"10.1378\/chest.125.6.2135_bib24","series-title":"Legionella: current status and emerging perspectives","first-page":"36","article-title":"Preliminary findings of a community-based pneumonia incidence study","author":"Marston","year":"1993"},{"key":"10.1378\/chest.125.6.2135_bib25","series-title":"Waterborne pathogens: Legionella and other opportunistic pathogens","author":"Squier","year":"2001"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216589879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216589879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T03:30:32Z","timestamp":1624419032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216589879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0012369216589879"],"URL":"https:\/\/doi.org\/10.1378\/chest.125.6.2135","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}